title: [Cost effectiveness of screening for prostate cancer].
abstract: According to most experts, problems of prostate cancer (PC) have reached world-wide social and economic resonance at the turn of the 21st century. Costly programs of diagnosis and treatment of generalized PC and its complications require most spending. The general demographic situation and increased aging of male populations, both worldwide and in this country, make it clear that the total costs of medical aid to PC patients will inevitably grow. However, programs of screening for PC can help.
authors.forename: A D
authors.initials: AD
authors.lastname: Kaprin
authors.forename: N B
authors.initials: NB
authors.lastname: Naĭgovzina
authors.forename: S A
authors.initials: SA
authors.lastname: Ivanov
authors.forename: V A
authors.initials: VA
authors.lastname: Bashmakov
mesh_terms: D000328:Adult; D000368:Aged; D003362:Cost-Benefit Analysis; D007172:Erectile Dysfunction / Q000191:economics; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000191:economics; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000191:economics*; D011472:Prostatitis / Q000175:diagnosis / Q000191:economics; D012426:Russia; D014549:Urinary Incontinence / Q000191:economics; D052878:Urolithiasis / Q000191:economics